Susquehanna International Group’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-64,600
Closed -$74K 10367
2017
Q1
$74K Sell
64,600
-18,000
-22% -$23.4K ﹤0.01% 8499
2016
Q4
$102K Buy
82,600
+6,500
+9% +$12K ﹤0.01% 9079
2016
Q3
$196K Buy
76,100
+12,400
+19% +$27K ﹤0.01% 7600
2016
Q2
$123K Buy
63,700
+46,700
+275% +$113K ﹤0.01% 7925
2016
Q1
$28K Buy
+17,000
New +$36.5K ﹤0.01% 8778
2015
Q4
Sell
-5,907
Closed -$25K 10384
2015
Q3
$25K Sell
5,907
-5,493
-48% -$36.4K ﹤0.01% 9474
2015
Q2
$109K Sell
11,400
-10,821
-49% -$152K ﹤0.01% 9639
2015
Q1
$370K Buy
22,221
+6,664
+43% +$131K ﹤0.01% 7630
2014
Q4
$253K Buy
15,557
+7,407
+91% +$163K ﹤0.01% 8413
2014
Q3
$210K Buy
8,150
+1,429
+21% +$34.5K ﹤0.01% 8604
2014
Q2
$167K Buy
6,721
+2,371
+55% +$60.6K ﹤0.01% 9193
2014
Q1
$131K Sell
4,350
-4,529
-51% -$152K ﹤0.01% 8481
2013
Q4
$280K Buy
8,879
+7,529
+558% +$235K ﹤0.01% 7693
2013
Q3
$37K Sell
1,350
-371
-22% -$8.99K ﹤0.01% 8276
2013
Q2
$37K Buy
+1,721
New +$42.4K ﹤0.01% 8030

Other funds holding WINT

Susquehanna International Group's WINT Position: Q3 2015 in Review

Susquehanna International Group sold out of Windtree Therapeutics Inc (WINT) in Q3 2015, closing a stake of 2,889 shares — an estimated $19.1K sold.

Susquehanna International Group first reported a position in WINT in Q2 2013 and held it in 8 quarters. The position peaked at $710K in Q1 2014. 48 funds tracked by Wall St. Rank hold WINT as of Q3 2015.

  • Susquehanna International Group reported no remaining Windtree Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 2,889 Windtree Therapeutics Inc shares in Q3 2015, an estimated $19.1K.
  • Susquehanna International Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 8 quarters.
  • Susquehanna International Group's Windtree Therapeutics Inc position peaked at $710K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.